TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 19, No. 13 June 3, 2013
__________________________________________________________
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
UPCOMING MEETINGS & EVENTS
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 19, No. 13 June 3, 2013
(The next issue will be on July 15, 2013)
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None Submitted for this issue.
__________________________________________________________None Submitted for this issue.
UPCOMING MEETINGS & EVENTS
General info on upcoming meetings:
http://tf7.org/meetings.htm
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1-1FmVuMr47LFJ9FM0jv2X8/
(2013) [Recombinant activated factor VII use for the bleeding implications prevention during central venous catheterization in pediatric patients with acute leucosis and thrombocytopenia]. Anesteziol Reanimatol:18-21.
http://www.ncbi.nlm.nih.gov/pubmed/23808247
Aditya S (2012) Oral and parenteral anticoagulants: new kids on the block. J Postgrad Med 58:275-285.
http://www.ncbi.nlm.nih.gov/pubmed/23298923
Arakawa N, Miyagi E, Nomura A, Morita E, Ino Y, Ohtake N, . . . Hirano H (2013) Secretome-based identification of TFPI2, a novel serum biomarker for detection of ovarian clear cell adenocarcinoma. J Proteome Res.
http://www.ncbi.nlm.nih.gov/pubmed/23805888
Beleva E, Grudeva-Popova J (2013) From Virchow's triad to metastasis: circulating hemostatic factors as predictors of risk for metastasis in solid tumors. J BUON 18:25-33.
http://www.ncbi.nlm.nih.gov/pubmed/23613385
Besseling J, Meijers JC, Hutten BA, Trip MD, Hovingh GK (2013) Statin Therapy and Levels of Hemostatic Factors in a Healthy Population: the Multi-Ethnic Study of Atherosclerosis: a rebuttal. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/23809272
Brummel-Ziedins KE, Lam PH, Gissel M, Gauthier E, Schneider DJ (2013) Depletion of systemic concentrations of coagulation factors in blood from patients with atherosclerotic vascular disease. Coron Artery Dis.
http://www.ncbi.nlm.nih.gov/pubmed/23787362
Cechin SR, Perez-Alvarez I, Fenjves E, Molano RD, Pileggi A, Berggren PO, . . . Pastori RL (2012) Anti-inflammatory properties of exenatide in human pancreatic islets. Cell Transplant 21:633-648.
http://www.ncbi.nlm.nih.gov/pubmed/21669040
Choi Q, Kim JE, Hyun J, Han KS, Kim HK (2013) Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: Potential role of protein Z as a powerful determinant of coagulation assays. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/23769659
Collins PW (2012) Therapeutic challenges in acquired factor VIII deficiency. Hematology Am Soc Hematol Educ Program 2012:369-374.
http://www.ncbi.nlm.nih.gov/pubmed/23233606
Ettelaie C, Collier ME, Mei MP, Xiao YP, Maraveyas A (2013) Enhanced binding of tissue factor-microparticles to collagen-IV and fibronectin leads to increased tissue factor activity in vitro. Thromb Haemost 109:61-71.
http://www.ncbi.nlm.nih.gov/pubmed/23152142
Ferjancic S, Gil-Bernabe AM, Hill SA, Allen PD, Richardson P, Sparey T, . . . Muschel RJ (2013) VCAM-1 and VAP-1 recruit myeloid cells that promote pulmonary metastasis in mice. Blood 121:3289-3297.
http://www.ncbi.nlm.nih.gov/pubmed/23407548
Geddings JE, Mackman N (2013) Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood.
http://www.ncbi.nlm.nih.gov/pubmed/23798713
Gheldof D, Mullier F, Chatelain B, Dogne JM, Chatelain C (2013) Inhibition of tissue factor pathway inhibitor increases the sensitivity of thrombin generation assay to procoagulant microvesicles. Blood Coagul Fibrinolysis 24:567-572.
http://www.ncbi.nlm.nih.gov/pubmed/23807485
Habib SS (2013) Plasma tissue factor pathway inhibitor levels in angiographically defined coronary artery disease among saudis. Oman Med J 28:191-194.
http://www.ncbi.nlm.nih.gov/pubmed/23772285
Hernandez C, Orbe J, Roncal C, Alvarez-Hernandez M, Martinez de Lizarrondo S, Alves MT, . . . Paramo JA (2013) Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients. Thromb Haemost 110.
http://www.ncbi.nlm.nih.gov/pubmed/23803792
Holster IL, Hunfeld NG, Kuipers EJ, Kruip MJ, Tjwa ET (2013) On the treatment of new oral anticoagulant-associated gastrointestinal hemorrhage. J Gastrointestin Liver Dis 22:229-231.
http://www.ncbi.nlm.nih.gov/pubmed/23799225
Hot A, Lavocat F, Lenief V, Miossec P (2013) Simvastatin inhibits the pro-inflammatory and pro-thrombotic effects of IL-17 and TNF-alpha on endothelial cells. Ann Rheum Dis 72:754-760.
http://www.ncbi.nlm.nih.gov/pubmed/22915623
Irons EE, Flatt JW, Doronin K, Fox TL, Acchione M, Stewart PL, Shayakhmetov DM (2013) Coagulation factor binding orientation and dimerization may influence infectivity of adenovirus-coagulation factor complexes. J Virol.
http://www.ncbi.nlm.nih.gov/pubmed/23804638
Kato M, Atsumi T, Oku K, Amengual O, Nakagawa H, Fujieda Y, . . . Koike T (2013) The involvement of CD36 in monocyte activation by antiphospholipid antibodies. Lupus 22:761-771.
http://www.ncbi.nlm.nih.gov/pubmed/23817509
Khorana AA (2012) Cancer-associated thrombosis: updates and controversies. Hematology Am Soc Hematol Educ Program 2012:626-630.
http://www.ncbi.nlm.nih.gov/pubmed/23233644
Kiessling AH, Nitsch J, Strouhal U, Kornberger A, Zierer A, Moritz A (2013) Associated Risk of Recombinant Activated Factor VIIa Application. Heart Surg Forum 16:E132-136.
http://www.ncbi.nlm.nih.gov/pubmed/23803235
Kim G, Kim H, Kim KN, Son JI, Kim SY, Tamura T, Chang N (2013) Relationship of cognitive function with B vitamin status, homocysteine, and tissue factor pathway inhibitor in cognitively impaired elderly: a cross-sectional survey. J Alzheimers Dis 33:853-862.
http://www.ncbi.nlm.nih.gov/pubmed/23042212
Kim JH, Oh BJ, Lee HN, Park HS, Park SG, Park KS (2011) Endothelial colony-forming cell coating of pig islets prevents xenogeneic instant blood-mediated inflammatory reaction. Cell Transplant 20:1805-1815.
http://www.ncbi.nlm.nih.gov/pubmed/21396165
Kocaturk B, Van den Berg YW, Tieken C, Mieog JS, de Kruijf EM, Engels CC, . . . Versteeg HH (2013) Alternatively spliced tissue factor promotes breast cancer growth in a beta1 integrin-dependent manner. Proc Natl Acad Sci U S A.
http://www.ncbi.nlm.nih.gov/pubmed/23801760
Krikun G, Trezza J, Shaw J, Rahman M, Guller S, Abrahams VM, Lockwood CJ (2012) Lipopolysaccharide appears to activate human endometrial endothelial cells through TLR-4-dependent and TLR-4-independent mechanisms. Am J Reprod Immunol 68:233-237.
http://www.ncbi.nlm.nih.gov/pubmed/22672000
Lazo-Langner A, Lang ES, Douketis J (2013) Clinical review: Clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications. Crit Care 17:230.
http://www.ncbi.nlm.nih.gov/pubmed/23806169
Lenk C, Unterthurner S, Schuster M, Weiller M, Antoine G, Malisauskas M, . . . Reipert BM (2013) Development of a Transgenic Mouse Model with Immune Tolerance for Human Coagulation Factor VIIa. Pharm Res.
http://www.ncbi.nlm.nih.gov/pubmed/23775444
Liew A, Eikelboom JW, O'Donnell M, Hart RG (2013) Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants. Can J Cardiol 29:S34-44.
http://www.ncbi.nlm.nih.gov/pubmed/23790596
Lin M, Weng H, Wang X, Zhou B, Yu P, Wang Y (2012) The role of tissue factor and protease-activated receptor 2 in endometriosis. Am J Reprod Immunol 68:251-257.
http://www.ncbi.nlm.nih.gov/pubmed/22672593
Liu X, Sun J (2013) Time-course effects of intravenously administrated silica nanoparticles on blood coagulation and endothelial function in rats. J Nanosci Nanotechnol 13:222-228.
http://www.ncbi.nlm.nih.gov/pubmed/23646720
Louw E, van der Merwe NA, Neitz AW, Maritz-Olivier C (2013) Evolution of the tissue factor pathway inhibitor-like Kunitz domain-containing protein family in Rhipicephalus microplus. Int J Parasitol 43:81-94.
http://www.ncbi.nlm.nih.gov/pubmed/23220044
Lu HY, Chen D, Gu J, Song LX, Chen M (2013) [Tissue Factor Expression of Platelets and Leukocytes in Patients with Acute Coronary Syndromes.]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 21:678-683.
http://www.ncbi.nlm.nih.gov/pubmed/23815921
Mackinder MA, Evans CA, Chowdry J, Staton CA, Corfe BM (2012) Alteration in composition of keratin intermediate filaments in a model of breast cancer progression and the potential to reverse hallmarks of metastasis. Cancer Biomark 12:49-64.
http://www.ncbi.nlm.nih.gov/pubmed/23396250
Matan M, Axelman E, Brenner B, Nadir Y (2013) Heparanase procoagulant activity is elevated in women using oral contraceptives. Hum Reprod.
http://www.ncbi.nlm.nih.gov/pubmed/23800622
Menkis AH, Martin J, Cheng DC, Fitzgerald DC, Freedman JJ, Gao C, . . . Ad N (2012) Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011. Innovations (Phila) 7:229-241.
http://www.ncbi.nlm.nih.gov/pubmed/23123988
Nakabayashi T, Gotoh Y, Kamada N, Fujioka M, Ishihara T, Hirabayashi A, Sato H (2013) Pharmacokinetics of the amidine prodrug of a novel oral anticoagulant factor VIIa inhibitor (AS1924269-00) in rats. Pharmazie 68:349-354.
http://www.ncbi.nlm.nih.gov/pubmed/23802432
Nieuwenhuizen L, Falkenburg WJ, Schutgens RE, Roosendaal G, van Veghel K, Biesma DH, Lafeber FP (2013) Stimulation of naive monocytes and PBMCs with coagulation proteases results in thrombin-mediated and PAR-1-dependent cytokine release and cell proliferation in PBMCs only. Scand J Immunol 77:339-349.
http://www.ncbi.nlm.nih.gov/pubmed/23421536
Papareddy P, Kalle M, Sorensen OE, Lundqvist K, Morgelin M, Malmsten M, Schmidtchen A (2012) Tissue factor pathway inhibitor 2 is found in skin and its C-terminal region encodes for antibacterial activity. PLoS One 7:e52772.
http://www.ncbi.nlm.nih.gov/pubmed/23300768
Pena E, Arderiu G, Badimon L (2013) Tissue Factor Induces Human Coronary Artery Smooth Muscle Cell Motility through Wnt-Signalling. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/23782925
Peng W, Yu Y, Li T, Zhu Y, Chen H (2013) The effects of small interfering RNA-targeting tissue factor on an in vitro model of neovascularization. Mol Vis 19:1296-1303.
http://www.ncbi.nlm.nih.gov/pubmed/23805036
Perry JR (2012) Thromboembolic disease in patients with high-grade glioma. Neuro Oncol 14 Suppl 4:iv73-80.
http://www.ncbi.nlm.nih.gov/pubmed/23095833
Pham HP, Hsu SX, Parker-Jones S, Samstein B, Diuguid D, Schwartz J (2013) Recombinant activated factor VII in patients with acute liver failure with UNOS Status 1A: a single tertiary academic centre experience. Vox Sang.
http://www.ncbi.nlm.nih.gov/pubmed/23815226
Poursafa P, Kelishadi R, Haghjooy-Javanmard S, Rafiei L, Keramatian K (2012) Synergistic effects of genetic polymorphism and air pollution on markers of endothelial dysfunction in children. J Res Med Sci 17:718-723.
http://www.ncbi.nlm.nih.gov/pubmed/23798936
Rodriguez-Merchan EC (2012) Orthopedic surgery is possible in hemophilic patients with inhibitors. Am J Orthop (Belle Mead NJ) 41:570-574.
http://www.ncbi.nlm.nih.gov/pubmed/23431528
Rossetto V, Spiezia L, Senzolo M, Rodriguez K, Gavasso S, Woodhams B, Simioni P (2013) Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosis. Int J Lab Hematol 35:101-105.
http://www.ncbi.nlm.nih.gov/pubmed/22958499
Samama MM, Conard J, Lillo-Le Louet A (2013) [Hemorrhagic accidents of the new oral anticoagulants and coagulation assays.]. J Mal Vasc.
http://www.ncbi.nlm.nih.gov/pubmed/23790307
Sartori MT, Della Puppa A, Ballin A, Campello E, Radu CM, Saggiorato G, . . . Simioni P (2013) Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role. Thromb Haemost 110.
http://www.ncbi.nlm.nih.gov/pubmed/23803674
Schulman S (2012) Pharmacologic tools to reduce bleeding in surgery. Hematology Am Soc Hematol Educ Program 2012:517-521.
http://www.ncbi.nlm.nih.gov/pubmed/23233628
Shibeko AM, Ataullakhanov FI (2013) [Role of spatio-temporal non uniformities in blood coagulation regulation]. Ross Fiziol Zh Im I M Sechenova 99:33-43.
http://www.ncbi.nlm.nih.gov/pubmed/23659054
Shrivastava S, Ma L, Tham el L, J HM, Chen D, Dorling A (2013) Protease-activated receptor-2 signalling by tissue factor on dendritic cells suppresses antigen-specific CD4+ T-cell priming. Immunology 139:219-226.
http://www.ncbi.nlm.nih.gov/pubmed/23347132
Uruga H, Fujii T, Kurosaki A, Hanada S, Takaya H, Miyamoto A, . . . Kishi K (2013) Pulmonary tumor thrombotic microangiopathy: a clinical analysis of 30 autopsy cases. Intern Med 52:1317-1323.
http://www.ncbi.nlm.nih.gov/pubmed/23774540
von Kanel R, Natarajan L, Ancoli-Israel S, Mills PJ, Wolfson T, Gamst AC, . . . Dimsdale JE (2013) Effect of continuous positive airway pressure on day/night rhythm of prothrombotic markers in obstructive sleep apnea. Sleep Med 14:58-65.
http://www.ncbi.nlm.nih.gov/pubmed/23036264
Walsh CL, Nguyen J, Tiffany MR, Szoka FC (2013) Synthesis, characterization, and evaluation of ionizable lysine-based lipids for siRNA delivery. Bioconjug Chem 24:36-43.
http://www.ncbi.nlm.nih.gov/pubmed/23176544
Wong PC, White A, Luettgen J (2013) Inhibitory effect of apixaban compared with rivaroxaban and dabigatran on thrombin generation assay. Hosp Pract (1995) 41:19-25.
http://www.ncbi.nlm.nih.gov/pubmed/23466964
Zangari M, Berno T, Zhan F, Tricot G, Fink L (2012) Mechanisms of thrombosis in paraproteinemias: the effects of immunomodulatory drugs. Semin Thromb Hemost 38:768-779.
http://www.ncbi.nlm.nih.gov/pubmed/23104518
Zderic TW, Hamilton MT (2012) Identification of hemostatic genes expressed in human and rat leg muscles and a novel gene (LPP1/PAP2A) suppressed during prolonged physical inactivity (sitting). Lipids Health Dis 11:137.
http://www.ncbi.nlm.nih.gov/pubmed/23061662
Zhang Y, Wang L, Zhou W, Wang H, Zhang J, Deng S, . . . Ma D (2013) Tissue factor pathway inhibitor-2: A novel gene involved in zebrafish central nervous system development. Dev Biol.
http://www.ncbi.nlm.nih.gov/pubmed/23796905
Zhou W, Zorn M, Nawroth P, Butehorn U, Perzborn E, Heitmeier S, Veltkamp R (2013) Hemostatic therapy in experimental intracerebral hemorrhage associated with rivaroxaban. Stroke 44:771-778.
http://www.ncbi.nlm.nih.gov/pubmed/23339956
Zwicker JI, Liebman HA, Bauer KA, Caughey T, Campigotto F, Rosovsky R, . . . Furie B (2013) Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study). Br J Haematol 160:530-537.
http://www.ncbi.nlm.nih.gov/pubmed/23240761
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1-1FmVuMr47LFJ9FM0jv2X8/
(2013) [Recombinant activated factor VII use for the bleeding implications prevention during central venous catheterization in pediatric patients with acute leucosis and thrombocytopenia]. Anesteziol Reanimatol:18-21.
http://www.ncbi.nlm.nih.gov/pubmed/23808247
Aditya S (2012) Oral and parenteral anticoagulants: new kids on the block. J Postgrad Med 58:275-285.
http://www.ncbi.nlm.nih.gov/pubmed/23298923
Arakawa N, Miyagi E, Nomura A, Morita E, Ino Y, Ohtake N, . . . Hirano H (2013) Secretome-based identification of TFPI2, a novel serum biomarker for detection of ovarian clear cell adenocarcinoma. J Proteome Res.
http://www.ncbi.nlm.nih.gov/pubmed/23805888
Beleva E, Grudeva-Popova J (2013) From Virchow's triad to metastasis: circulating hemostatic factors as predictors of risk for metastasis in solid tumors. J BUON 18:25-33.
http://www.ncbi.nlm.nih.gov/pubmed/23613385
Besseling J, Meijers JC, Hutten BA, Trip MD, Hovingh GK (2013) Statin Therapy and Levels of Hemostatic Factors in a Healthy Population: the Multi-Ethnic Study of Atherosclerosis: a rebuttal. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/23809272
Brummel-Ziedins KE, Lam PH, Gissel M, Gauthier E, Schneider DJ (2013) Depletion of systemic concentrations of coagulation factors in blood from patients with atherosclerotic vascular disease. Coron Artery Dis.
http://www.ncbi.nlm.nih.gov/pubmed/23787362
Cechin SR, Perez-Alvarez I, Fenjves E, Molano RD, Pileggi A, Berggren PO, . . . Pastori RL (2012) Anti-inflammatory properties of exenatide in human pancreatic islets. Cell Transplant 21:633-648.
http://www.ncbi.nlm.nih.gov/pubmed/21669040
Choi Q, Kim JE, Hyun J, Han KS, Kim HK (2013) Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: Potential role of protein Z as a powerful determinant of coagulation assays. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/23769659
Collins PW (2012) Therapeutic challenges in acquired factor VIII deficiency. Hematology Am Soc Hematol Educ Program 2012:369-374.
http://www.ncbi.nlm.nih.gov/pubmed/23233606
Ettelaie C, Collier ME, Mei MP, Xiao YP, Maraveyas A (2013) Enhanced binding of tissue factor-microparticles to collagen-IV and fibronectin leads to increased tissue factor activity in vitro. Thromb Haemost 109:61-71.
http://www.ncbi.nlm.nih.gov/pubmed/23152142
Ferjancic S, Gil-Bernabe AM, Hill SA, Allen PD, Richardson P, Sparey T, . . . Muschel RJ (2013) VCAM-1 and VAP-1 recruit myeloid cells that promote pulmonary metastasis in mice. Blood 121:3289-3297.
http://www.ncbi.nlm.nih.gov/pubmed/23407548
Geddings JE, Mackman N (2013) Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood.
http://www.ncbi.nlm.nih.gov/pubmed/23798713
Gheldof D, Mullier F, Chatelain B, Dogne JM, Chatelain C (2013) Inhibition of tissue factor pathway inhibitor increases the sensitivity of thrombin generation assay to procoagulant microvesicles. Blood Coagul Fibrinolysis 24:567-572.
http://www.ncbi.nlm.nih.gov/pubmed/23807485
Habib SS (2013) Plasma tissue factor pathway inhibitor levels in angiographically defined coronary artery disease among saudis. Oman Med J 28:191-194.
http://www.ncbi.nlm.nih.gov/pubmed/23772285
Hernandez C, Orbe J, Roncal C, Alvarez-Hernandez M, Martinez de Lizarrondo S, Alves MT, . . . Paramo JA (2013) Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients. Thromb Haemost 110.
http://www.ncbi.nlm.nih.gov/pubmed/23803792
Holster IL, Hunfeld NG, Kuipers EJ, Kruip MJ, Tjwa ET (2013) On the treatment of new oral anticoagulant-associated gastrointestinal hemorrhage. J Gastrointestin Liver Dis 22:229-231.
http://www.ncbi.nlm.nih.gov/pubmed/23799225
Hot A, Lavocat F, Lenief V, Miossec P (2013) Simvastatin inhibits the pro-inflammatory and pro-thrombotic effects of IL-17 and TNF-alpha on endothelial cells. Ann Rheum Dis 72:754-760.
http://www.ncbi.nlm.nih.gov/pubmed/22915623
Irons EE, Flatt JW, Doronin K, Fox TL, Acchione M, Stewart PL, Shayakhmetov DM (2013) Coagulation factor binding orientation and dimerization may influence infectivity of adenovirus-coagulation factor complexes. J Virol.
http://www.ncbi.nlm.nih.gov/pubmed/23804638
Kato M, Atsumi T, Oku K, Amengual O, Nakagawa H, Fujieda Y, . . . Koike T (2013) The involvement of CD36 in monocyte activation by antiphospholipid antibodies. Lupus 22:761-771.
http://www.ncbi.nlm.nih.gov/pubmed/23817509
Khorana AA (2012) Cancer-associated thrombosis: updates and controversies. Hematology Am Soc Hematol Educ Program 2012:626-630.
http://www.ncbi.nlm.nih.gov/pubmed/23233644
Kiessling AH, Nitsch J, Strouhal U, Kornberger A, Zierer A, Moritz A (2013) Associated Risk of Recombinant Activated Factor VIIa Application. Heart Surg Forum 16:E132-136.
http://www.ncbi.nlm.nih.gov/pubmed/23803235
Kim G, Kim H, Kim KN, Son JI, Kim SY, Tamura T, Chang N (2013) Relationship of cognitive function with B vitamin status, homocysteine, and tissue factor pathway inhibitor in cognitively impaired elderly: a cross-sectional survey. J Alzheimers Dis 33:853-862.
http://www.ncbi.nlm.nih.gov/pubmed/23042212
Kim JH, Oh BJ, Lee HN, Park HS, Park SG, Park KS (2011) Endothelial colony-forming cell coating of pig islets prevents xenogeneic instant blood-mediated inflammatory reaction. Cell Transplant 20:1805-1815.
http://www.ncbi.nlm.nih.gov/pubmed/21396165
Kocaturk B, Van den Berg YW, Tieken C, Mieog JS, de Kruijf EM, Engels CC, . . . Versteeg HH (2013) Alternatively spliced tissue factor promotes breast cancer growth in a beta1 integrin-dependent manner. Proc Natl Acad Sci U S A.
http://www.ncbi.nlm.nih.gov/pubmed/23801760
Krikun G, Trezza J, Shaw J, Rahman M, Guller S, Abrahams VM, Lockwood CJ (2012) Lipopolysaccharide appears to activate human endometrial endothelial cells through TLR-4-dependent and TLR-4-independent mechanisms. Am J Reprod Immunol 68:233-237.
http://www.ncbi.nlm.nih.gov/pubmed/22672000
Lazo-Langner A, Lang ES, Douketis J (2013) Clinical review: Clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications. Crit Care 17:230.
http://www.ncbi.nlm.nih.gov/pubmed/23806169
Lenk C, Unterthurner S, Schuster M, Weiller M, Antoine G, Malisauskas M, . . . Reipert BM (2013) Development of a Transgenic Mouse Model with Immune Tolerance for Human Coagulation Factor VIIa. Pharm Res.
http://www.ncbi.nlm.nih.gov/pubmed/23775444
Liew A, Eikelboom JW, O'Donnell M, Hart RG (2013) Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants. Can J Cardiol 29:S34-44.
http://www.ncbi.nlm.nih.gov/pubmed/23790596
Lin M, Weng H, Wang X, Zhou B, Yu P, Wang Y (2012) The role of tissue factor and protease-activated receptor 2 in endometriosis. Am J Reprod Immunol 68:251-257.
http://www.ncbi.nlm.nih.gov/pubmed/22672593
Liu X, Sun J (2013) Time-course effects of intravenously administrated silica nanoparticles on blood coagulation and endothelial function in rats. J Nanosci Nanotechnol 13:222-228.
http://www.ncbi.nlm.nih.gov/pubmed/23646720
Louw E, van der Merwe NA, Neitz AW, Maritz-Olivier C (2013) Evolution of the tissue factor pathway inhibitor-like Kunitz domain-containing protein family in Rhipicephalus microplus. Int J Parasitol 43:81-94.
http://www.ncbi.nlm.nih.gov/pubmed/23220044
Lu HY, Chen D, Gu J, Song LX, Chen M (2013) [Tissue Factor Expression of Platelets and Leukocytes in Patients with Acute Coronary Syndromes.]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 21:678-683.
http://www.ncbi.nlm.nih.gov/pubmed/23815921
Mackinder MA, Evans CA, Chowdry J, Staton CA, Corfe BM (2012) Alteration in composition of keratin intermediate filaments in a model of breast cancer progression and the potential to reverse hallmarks of metastasis. Cancer Biomark 12:49-64.
http://www.ncbi.nlm.nih.gov/pubmed/23396250
Matan M, Axelman E, Brenner B, Nadir Y (2013) Heparanase procoagulant activity is elevated in women using oral contraceptives. Hum Reprod.
http://www.ncbi.nlm.nih.gov/pubmed/23800622
Menkis AH, Martin J, Cheng DC, Fitzgerald DC, Freedman JJ, Gao C, . . . Ad N (2012) Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011. Innovations (Phila) 7:229-241.
http://www.ncbi.nlm.nih.gov/pubmed/23123988
Nakabayashi T, Gotoh Y, Kamada N, Fujioka M, Ishihara T, Hirabayashi A, Sato H (2013) Pharmacokinetics of the amidine prodrug of a novel oral anticoagulant factor VIIa inhibitor (AS1924269-00) in rats. Pharmazie 68:349-354.
http://www.ncbi.nlm.nih.gov/pubmed/23802432
Nieuwenhuizen L, Falkenburg WJ, Schutgens RE, Roosendaal G, van Veghel K, Biesma DH, Lafeber FP (2013) Stimulation of naive monocytes and PBMCs with coagulation proteases results in thrombin-mediated and PAR-1-dependent cytokine release and cell proliferation in PBMCs only. Scand J Immunol 77:339-349.
http://www.ncbi.nlm.nih.gov/pubmed/23421536
Papareddy P, Kalle M, Sorensen OE, Lundqvist K, Morgelin M, Malmsten M, Schmidtchen A (2012) Tissue factor pathway inhibitor 2 is found in skin and its C-terminal region encodes for antibacterial activity. PLoS One 7:e52772.
http://www.ncbi.nlm.nih.gov/pubmed/23300768
Pena E, Arderiu G, Badimon L (2013) Tissue Factor Induces Human Coronary Artery Smooth Muscle Cell Motility through Wnt-Signalling. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/23782925
Peng W, Yu Y, Li T, Zhu Y, Chen H (2013) The effects of small interfering RNA-targeting tissue factor on an in vitro model of neovascularization. Mol Vis 19:1296-1303.
http://www.ncbi.nlm.nih.gov/pubmed/23805036
Perry JR (2012) Thromboembolic disease in patients with high-grade glioma. Neuro Oncol 14 Suppl 4:iv73-80.
http://www.ncbi.nlm.nih.gov/pubmed/23095833
Pham HP, Hsu SX, Parker-Jones S, Samstein B, Diuguid D, Schwartz J (2013) Recombinant activated factor VII in patients with acute liver failure with UNOS Status 1A: a single tertiary academic centre experience. Vox Sang.
http://www.ncbi.nlm.nih.gov/pubmed/23815226
Poursafa P, Kelishadi R, Haghjooy-Javanmard S, Rafiei L, Keramatian K (2012) Synergistic effects of genetic polymorphism and air pollution on markers of endothelial dysfunction in children. J Res Med Sci 17:718-723.
http://www.ncbi.nlm.nih.gov/pubmed/23798936
Rodriguez-Merchan EC (2012) Orthopedic surgery is possible in hemophilic patients with inhibitors. Am J Orthop (Belle Mead NJ) 41:570-574.
http://www.ncbi.nlm.nih.gov/pubmed/23431528
Rossetto V, Spiezia L, Senzolo M, Rodriguez K, Gavasso S, Woodhams B, Simioni P (2013) Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosis. Int J Lab Hematol 35:101-105.
http://www.ncbi.nlm.nih.gov/pubmed/22958499
Samama MM, Conard J, Lillo-Le Louet A (2013) [Hemorrhagic accidents of the new oral anticoagulants and coagulation assays.]. J Mal Vasc.
http://www.ncbi.nlm.nih.gov/pubmed/23790307
Sartori MT, Della Puppa A, Ballin A, Campello E, Radu CM, Saggiorato G, . . . Simioni P (2013) Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role. Thromb Haemost 110.
http://www.ncbi.nlm.nih.gov/pubmed/23803674
Schulman S (2012) Pharmacologic tools to reduce bleeding in surgery. Hematology Am Soc Hematol Educ Program 2012:517-521.
http://www.ncbi.nlm.nih.gov/pubmed/23233628
Shibeko AM, Ataullakhanov FI (2013) [Role of spatio-temporal non uniformities in blood coagulation regulation]. Ross Fiziol Zh Im I M Sechenova 99:33-43.
http://www.ncbi.nlm.nih.gov/pubmed/23659054
Shrivastava S, Ma L, Tham el L, J HM, Chen D, Dorling A (2013) Protease-activated receptor-2 signalling by tissue factor on dendritic cells suppresses antigen-specific CD4+ T-cell priming. Immunology 139:219-226.
http://www.ncbi.nlm.nih.gov/pubmed/23347132
Uruga H, Fujii T, Kurosaki A, Hanada S, Takaya H, Miyamoto A, . . . Kishi K (2013) Pulmonary tumor thrombotic microangiopathy: a clinical analysis of 30 autopsy cases. Intern Med 52:1317-1323.
http://www.ncbi.nlm.nih.gov/pubmed/23774540
von Kanel R, Natarajan L, Ancoli-Israel S, Mills PJ, Wolfson T, Gamst AC, . . . Dimsdale JE (2013) Effect of continuous positive airway pressure on day/night rhythm of prothrombotic markers in obstructive sleep apnea. Sleep Med 14:58-65.
http://www.ncbi.nlm.nih.gov/pubmed/23036264
Walsh CL, Nguyen J, Tiffany MR, Szoka FC (2013) Synthesis, characterization, and evaluation of ionizable lysine-based lipids for siRNA delivery. Bioconjug Chem 24:36-43.
http://www.ncbi.nlm.nih.gov/pubmed/23176544
Wong PC, White A, Luettgen J (2013) Inhibitory effect of apixaban compared with rivaroxaban and dabigatran on thrombin generation assay. Hosp Pract (1995) 41:19-25.
http://www.ncbi.nlm.nih.gov/pubmed/23466964
Zangari M, Berno T, Zhan F, Tricot G, Fink L (2012) Mechanisms of thrombosis in paraproteinemias: the effects of immunomodulatory drugs. Semin Thromb Hemost 38:768-779.
http://www.ncbi.nlm.nih.gov/pubmed/23104518
Zderic TW, Hamilton MT (2012) Identification of hemostatic genes expressed in human and rat leg muscles and a novel gene (LPP1/PAP2A) suppressed during prolonged physical inactivity (sitting). Lipids Health Dis 11:137.
http://www.ncbi.nlm.nih.gov/pubmed/23061662
Zhang Y, Wang L, Zhou W, Wang H, Zhang J, Deng S, . . . Ma D (2013) Tissue factor pathway inhibitor-2: A novel gene involved in zebrafish central nervous system development. Dev Biol.
http://www.ncbi.nlm.nih.gov/pubmed/23796905
Zhou W, Zorn M, Nawroth P, Butehorn U, Perzborn E, Heitmeier S, Veltkamp R (2013) Hemostatic therapy in experimental intracerebral hemorrhage associated with rivaroxaban. Stroke 44:771-778.
http://www.ncbi.nlm.nih.gov/pubmed/23339956
Zwicker JI, Liebman HA, Bauer KA, Caughey T, Campigotto F, Rosovsky R, . . . Furie B (2013) Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study). Br J Haematol 160:530-537.
http://www.ncbi.nlm.nih.gov/pubmed/23240761
__________________________________________________________
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
